# Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

> **NCT04370665** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 4 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DEVICE:** Exablate BBBD with Cerezyme

## Key facts

- **NCT ID:** NCT04370665
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-16
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-25
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370665, "Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04370665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*